Keywords: singulair, approved, use, younger, children, merck, co

Singulair approved for use in younger children

Article | 08 March 2000

Print This

Merck & Co's leukotriene inhibitor Singulair (montelukast sodium) hasbeen approved in the USA in a new 4mg tablet formulation for the ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in